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ABSTRACT
Establishment of infection by Trypanosoma cruzi, the agent of Chagas´ disease, depends on a series of events
involving interactions of diverse parasite molecules with host components. Here we focus on the mechanisms
of target cell invasion by metacyclic trypomastigotes (MT) and mammalian tissue culture trypomastigotes
(TCT). During MT or TCT internalization, signal transduction pathways are activated both in the parasite
and the target cell, leading to Ca2+ mobilization. For cell adhesion, MT engage surface glycoproteins, such
as gp82 and gp35/50, which are Ca2+ signal-inducing molecules. In T. cruzi isolates that enter host cells in
gp82-mediated manner, parasite protein tyrosine kinase as well as phospholipase C are activated, and Ca2+
is released from IP3-sensitive stores, whereas in T. cruzi isolates that attach to target cells mainly through
gp35/50, the signaling pathway involving adenylate cyclase appears to be stimulated, with Ca2+ release from
acidocalciosomes. In addition, T. cruzi isolate-dependent inhibitory signals, mediated by MT-specific gp90,
may be triggered both in the host cell and the parasite. The repertoire of TCT molecules implicated in cell
invasion includes surface glycoproteins of gp85 family, with members containing binding sites for laminin
and cytokeratin 18, enzymes such as cruzipain, trans-sialidase, and an oligopeptidase B that generates a
Ca2+-agonist from a precursor molecule.
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OVERVIEW
Trypanosoma cruzi is transmitted by insect vectors
when these blood-sucking triatomines deposit on the
skin their feces containing MT, the infective forms of
the parasite. Through the ocular mucosa or lesions
in the skin, the parasites find their way to invade host
cells. Metacyclic forms may enter mammalian hosts
also by oral route. According to Coura et al. (2002),
more than half of the acute cases of Chagas disease
recorded between 1968 and 2000 in Brazilian Ama-
zon can be attributed to microepidemics of orally
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transmitted infection from contaminated food. The
potential sources of contamination are whole tri-
atomine insects or their feces containing infective
parasites. Hoft (1996) has shown that MT are ef-
ficient in establishing infection in mice when given
orally. They enter the gastric mucosal epithelium,
transform into amastigotes and replicate intracellu-
larly (Hoft et al. 1996). Trypomastigotes emerge
from infected cells, circulate in the bloodstream and
disseminate to diverse organs and tissues. These cir-
culating parasites can be transmitted by blood trans-
fusion or congenitally. Following the acute phase,
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in which the parasites go through multiple rounds of
cell invasion and intracellular replication, their pro-
liferation is controlled by the host immune response.
Mammalian cell invasion by T. cruzi has been
extensively studied in vitro by using MT cultured
in liquid media and TCT, as counterparts of insect-
borne and bloodstream parasites respectively. Dif-
ferent T. cruzi isolates and a variety of cell types,
mostly cells that are not professional phagocytes,
have been used (Table I). The picture emerging from
these studies is that T. cruzi penetration into host
cells is a multi-step process involving various para-
site and host cell molecules that, in a concerted series
of events, leads to intracellular Ca2+ mobilization
in both cells (Docampo et al. 1996, Burleigh and
Andrews 1998, Yoshida 2003). Attachment of try-
pomastigotes is receptor-mediated and is restricted
to cell surface domains (Schenkman et al. 1991a).
For instance, parasites bind to and enter HeLa cells
at their edges and invade polarized MDCK cells
through their basolateral domains (Mortara 1991,
Schenkman et al. 1988a). To invade mammalian
cells, MT and TCT engage distinct sets of surface
molecules that differentially interact with host com-
ponents. The MT-specific glycoprotein gp82 binds
to gastric mucin (Neira et al. 2003) whereas mem-
bers of the TCT gp85 family have been shown to
bind components of extracelullar matrix, such as fi-
bronectin and laminin (Ouaissi et al. 1986a, Gior-
dano et al. 1994). Although MT gp82 and TCT
gp85 display differential adhesive properties and in-
teract with different receptors on target cells, they
are related molecules. They have considerable se-
quence identity (40-60%) and are included in the T.
cruzi gp85/sialidase superfamily (Araya et al. 1994,
Colli and Alves 1999). Mucin-like glycoproteins
constitute another group of molecules implicated in
host cell invasion that are differentially expressed
in MT and TCT. Mucins from MT are protease-
resistant gp35/50 molecules (Mortara et al. 1992,
Schenkman et al. 1993a), whereas TCT mucins are
larger molecules, migrating in SDS-PAGE as dif-
fuse bands between 70 and 200 kDa (Almeida et al.
1994, Schenkman et al. 1991b).
MT SURFACE MOLECULES THAT MEDIATE
BIDIRECTIONAL SIGNAL TRANSDUCTION
AND HOST CELL INVASION
Studies with MT of 10 T. cruzi isolates, derived
from different sources in distinct geographical re-
gions, have revealed two groups of parasites that
differentially express surface glycoproteins and dis-
play differential ability to invade mammalian cells
in vitro (Fig. 1). The two groups are highly diver-
gent. By molecular phylogenetic analysis, Briones
et al. (1999) have found that the distance between
the two T. cruzi lineages is larger than the distances
among Leishmania spp.
MT of highly invasive isolates are deficient in
gp90 and gp35/50, identified respectively by mon-
oclonal antibodies (MAbs) 1G7 and 10D8, but ex-
press the variant forms of gp90 and gp35/50, identi-
fied by MAbs 5E7 and 2B10. MT of poorly invasive
isolates express a gp90 molecule that is detectable
by MAbs 1G7 and 5E7, and gp35/50 molecules rec-
ognized by both MAbs 10D8 and 2B10. Expression
of gp82, which reacts with MAb 3F6, is ubiquitous
among these isolates (Fig. 1).
Gp35/50, gp82 and gp90 bind to as yet unde-
fined host cell receptors. The interaction of any of
these molecules with its receptor triggers bidirec-
tional signaling cascades. Whether the MT-target
cell interaction results in productive infection de-
pends on which surface molecule is predominantly
engaged. To attach to and enter host cells, MT
of highly invasive CL isolate, for instance, engage
gp82 (Ramirez et al. 1993), which efficiently trig-
gers Ca2+ signaling in MT and host cells (Ruiz et al.
1998), whereas MT of poorly invasive G isolate ap-
pear to rely mainly on gp35/50 for their internaliza-
tion (Yoshida et al. 1989). Gp35/50 molecules are
not as effective as gp82 in promoting invasion, due
probably to their poor Ca2+ signal-inducing activity
(Dorta et al. 1995). If the interaction is mediated
by gp90, which is devoid of Ca2+ signaling activity,
productive infection is precluded.
Extensive studies with MT of T. cruzi isolates
CL and G, which represent the prototypes of highly
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TABLE I
Mammalian cells and T. cruzi isolates used in invasion assays.
T. cruzi isolate or clone
CL, CL-14, Costalimai, Dm28, Dm28c, Dm30, F, MD, G, Guafitas,
M226, MD, 569, 588, Silvio X-10/4, RA, Tulahun, Y
Mammalian cell type
Chinese hamster ovary (CHO) cell
Human carcinoma-derived epithelial HeLa cell
Human umbilical vein endothelial cell (HUVEC)
L6E9 myoblast
LLC-MK2 cell
Madin-Darby canine kidney (MDCK) cell
Mouse 3T3 fibroblast,
My1Lu mink lung cell
Normal rat kidney (NRK) fibroblast
Primary canine cardiac myocyte
Vero cell derived from African green monkey fibroblast
and poorly invasive parasites, have shown that their
infectivity is not related to the target cell type. Re-
gardless of the mammalian cell type, the number of
internalized parasites of CL isolate is always several
fold higher than that of G isolate (Fig. 2A). These in
vitro findings closely correlate to the observations in
vivo. Regardless of the mouse strain or the route of
parasite administration, MT of CL isolate produce
high parasitemias, in contrast to MT of G isolate that
invariably produce subpatent infection (Fig. 2B).
Presumably the mechanisms of host cell entry acting
in vitro prevail in vivo. Invasion of epithelial HeLa
cells by MT may be equivalent to the invasion of gas-
tric mucosal epithelium, upon oral infection. Like-
wise, MT entry into mouse peritoneal macrophages,
whether the parasites are seeded onto cultured cells
or are inoculated intraperitoneally, may be equiva-
lent.
One interesting observation is that MT of
CL and G isolates are morphologically different
(Fig. 2C). As compared to CL isolate, parasites of
G isolate are shorter and the kinetoplast is more
proximal to the posterior end. Isolate-dependent
morphological variations are also observed in blood
trypomastigotes and the different morphologies ap-
parently denote physiological differences (Brener
1973). Slender forms appear to penetrate host cells
better than the stout forms (Brener 1969). In some T.
cruzi isolates, slender trypomastigotes are prevalent
during the first days of infection, whereas in other
isolates stout forms predominate during the entire
infection in mice (Brener 1973).
GP82, THE CA2+ SIGNAL-INDUCING MOLECULE
THAT PROMOTES CELL INVASION OF HIGHLY
INVASIVE T. cruzi ISOLATES
The role of the metacyclic stage-specific surface
molecule gp82 in mammalian cell invasion was first
determined by inhibition of MT internalization us-
ing MAb 3F6 or the purified native glycoprotein
(Ramirez et al. 1993). Subsequent studies indi-
cated that gp82 promotes MT entry into host cells
by inducing the activation of signaling cascades and
Ca2+ mobilization in both cells (Ruiz et al. 1998,
Yoshida et al. 2000). Recent studies with T. cruzi
clone CL-14, which is poorly infective, have further
reinforced the role played by gp82. When com-
pared to the parental CL isolate, the sole difference
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Fig. 1 – Mammalian cell invasion by MT of different T. cruzi isolates and profile of
surface molecules. In the upper panel is shown the infectivity of MT of the indicated
isolates, expressed as the number of internalized parasites per 100 cells, upon incubation
with HeLa cells for 3h at 37◦C. The values correspond to the means ± SD of five
experiments performed in duplicates, in which at least 500 Giemsa-stained cells were
counted. Shown in the lower panel are the profiles of surface molecules identified by
monoclonal antibodies directed to gp90, gp82 and gp35/50.
in the surface profile of clone CL-14 MT was the
deficient expression of gp82 (Atayde et al. 2004).
Gp82 is a glycoprotein containing N-linked
oligosaccharides (Ramirez et al. 1993) that is an-
chored to MT plasma membrane by glycosylphos-
phatidylinositol (GPI) moiety (Cardoso de Almeida
and Heise 1993). The identity of amino acid se-
quences of gp82 deduced from cDNA clones of G
and CL metacyclic forms is 97.9%, and 100%
as regards the central domain containing the mam-
malian cell binding site (Ruiz 1998). Using syn-
thetic peptides and truncated recombinant gp82
constructs, Manque et al. (2000) found that the cell
binding site is contiguous to and partially overlaps
the epitope for MAb 3F6, and appears to be confor-
mational, being possibly formed by juxtaposition
of two sequences separated in the linear molecule
by a hydrophobic stretch (Fig. 3).
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Fig. 2 – Differential in vitro and in vivo infectivity of T. cruzi isolates CL and G. A) MT infectivity upon incubation of parasites for 3h
with different cell types (HeLa, Vero or mouse peritoneal macrophages). The values, expressed as the number of internalized parasites
per 100 cells, correspond to the means ± SD of 10 (HeLa), 8 (Vero) or 5 (macrophage) experiments performed in duplicates, in which
at least 500 Giemsa-stained cells were counted. B) Course of infection upon inoculation of 4 × 105 MT by oral route into Balb/c mice,
or by intraperitoneal route into outbred Swiss mice. Each data point corresponds to the mean parasitemia of 6 animals. C) Purified
MT of CL and G isolates stained with Giemsa. Note that MT of CL isolate are longer and the kinetoplast is located more distal to the
posterior end, as compared to G isolate.
The central domain of MT gp82 shares 60-65%
identity with the C-terminal region of TCT glyco-
proteins of gp85 family. However, within the se-
quences containing the cell binding site and the epi-
tope for MAb 3F6, there are significant differences
between MT and TCT molecules, and these include
substitutions of acidic amino acids for uncharged
or positively charged residues, substitutions of un-
charged residues for lysine or arginine, and substi-
tutions of residues with polar side chains for those
with nonpolar side chains and vice-versa.
Binding of gp82 triggers in host cells a tran-
sient increase in intracellular Ca2+ concentration,
in the same manner as the soluble extracts of MT
(Fig. 4). Non infective epimastigotes do not induce
Ca2+ signaling (Tardieux et al. 1994, Dorta et al.
1995) unless they are transfected with T. cruzi ex-
pression vector carrying gp82 cDNA (Manque et al.
2003). Gp82 triggers Ca2+ response in mammalian
cells susceptible to T. cruzi infection, such as HeLa
and Vero cells, but not in T. cruzi-resistant human
leukemic K562 cells.
The kinetics of Ca2+ mobilization in MT is dis-
tinct from that observed in host cells and can be
triggered by soluble extracts of HeLa cells (Fig. 4),
but not of K562 cells, in a manner inhibitable by
native or recombinant gp82. Upon binding to host
cells, gp82 relays a signal to the parasite that re-
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Fig. 3 – Schematic representation of T. cruzi gp82. The sequence deduced from a cDNA clone derived
from MT of G isolate is represented, showing the epitope for MAb 3F6 and the host cell binding site,
which were mapped using synthetic peptides and truncated recombinant constructs of gp82.
Fig. 4 – Ca2+ response induced by T. cruzi-host cell interaction. Transient intracellular Ca2+
mobilization triggered in HeLa cells upon addition, at the indicated time (arrow), of sonicated
extract of MT or purified native gp82, is shown on the left. Note the lack of response by addition
of non-infective epimastigote (E) extract. Shown on the right is the Ca2+ response induced in MT,
but not in E, by sonicated HeLa cell extract.
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Fig. 5 – Activation of different signal transduction pathways in MT of phylogenetically distinct T. cruzi isolates during host cell
invasion. In the highly invasive CL isolate, the recognition of the surface molecule gp82 by its receptor leads to PTK activation,
phosphorylation of p175, activation of PLC and IP3 generation, culminating with IP3-mediated Ca2+ release from internal stores,
probably endoplasmic reticulum. The components of the G isolate signaling cascade, triggered at the cell surface by gp35/50, are
mostly unknown; cAMP generated by adenylyl cyclase may be involved, and acidocalcisomes appear to be the source of Ca2+ required
for parasite internalization.
sults in protein tyrosine kinase (PTK) activation
and phosphorylation of p175, a protein that is un-
detectable in noninfective epimastigotes (Favoreto
et al. 1998). Activation of PTK and Ca2+ response
are associated events, being both inhibited by gp82,
as well as by genistein, a specific inhibitor of PTK
(Yoshida et al. 2000). The signaling cascade in-
duced by gp82 includes the participation of phos-
pholipase C (PLC), that generates inositol 1,4,5-
triphosphate (IP3), as inferred from experiments in
which the parasite infectivity was impaired by PLC
inhibitor U73122, as well as by drugs, such as hep-
arin, a competitive IP3-receptor blocker, and caffein,
which affects Ca2+ release from IP3-sensitive stores
(Yoshida et al. 2000). Our hypothesis based on
these findings is that in MT of T. cruzi isolates that
engage gp82 to enter target cells, such as the CL
isolate, a signaling cascade is initiated at the para-
site cell surface by gp82 and proceeds downstream
through a sequence involving PTK, PLC and IP3,
leading to Ca2+ mobilization, possibly from endo-
plasmic reticulum (Fig. 5).
Many questions concerning the gp82-mediated
signaling cascade remain to be elucidated. One of
these is how gp82, which is GPI-anchored and there-
fore associates only with the outer leaflet of the MT
lipid bilayer, activates PTK. In mammalian cells,
association of GPI-anchored proteins and PTKs has
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been reported. A neuron survival factor neurturin,
for instance, signals through multicomplex recep-
tors that consist of receptor tyrosine kinase and a
member of a GPI-linked family of receptors that de-
termine ligand specificity (Buj-Bello et al. 1997).
In T cells, PTKs can be found in complexes im-
munoprecipitated with antibodies directed to GPI-
anchored proteins (Stefanova et al. 1991, Shenoy-
Scaria et al. 1992, Thomas and Samelson 1992).
An alternative possibility is the interaction of GPI-
anchored proteins and kinases mediated by trans-
membrane linker proteins, as suggested by Brown
(1993). Also awaiting elucidation is the question
concerning the connection between PTK or p175
and PLC.
GP82, A MEDIATOR OF INVASION OF GASTRIC
MUCOSAL EPITHELIUM
Recently, the involvement of gp82 in oral T. cruzi
infection was inferred from experiments in which
the infectivity of CL isolate MT was greatly reduced
upon treatment with anti-gp82 MAb 3F6 (Neira et
al. 2003). In addition to playing a critical role in
promoting invasion of gastric mucosal epithelium,
the ability of gp82 to bind to gastric mucin may
be important for the establishment of infection by
oral route. Shigella dysenteriae, for instance, whose
pathogenic potential is correlated with its ability
to invade and multiply within the cells of colonic
epithelium, preferentially adheres to colonic mucin
(Sudha et al. 2001).
The role of gp82 in establishing efficient T.
cruzi infection by oral route has been reinforced by
studies using gp82-deficient isolates, such as 569
and 588 (Cortez et al. 2003). When administered
orally into mice, MT of these gp82-deficient T. cruzi
isolates produce patent parasitemia, but to greatly
reduced levels when compared to isolate CL. Al-
though the in vivo infectivity of isolates 569 and
588 is lower than that of the CL isolate, the abil-
ity to enter host cells in vitro is similar. MT of
isolates 569 and 588 can efficiently invade cells in
vitro because they express gp30, a surface glyco-
protein detectable by MAb 3F6 and displaying Ca2+
signal-inducing activity. Gp30-mediated HeLa cell
entry of isolates 569 and 588, which is inhibited by
MAb 3F6 as well as by native gp30, is dependent
on the parasite signal transduction involving PTK
activation and Ca2+ mobilization from thapsigargin-
sensitive stores, similarly to the gp82-mediated sig-
naling. Notwithstanding the functional similarity
between gp82 and gp30, MT of gp82-deficient iso-
lates are less infective by oral route than the CL iso-
late, and this is probably due to the low efficiency of
gp30 in binding to gastric mucin. Accordingly, in
the presence of high concentration of gastric mucin,
to mimic the in vivo condition, the rate of HeLa cell
invasion of gp82-deficient MT, but not of CL iso-
late, was significantly reduced (Cortez et al. 2003).
These findings indicate that the host cell invasion
by MT can be mediated either by gp82 or gp30, but
efficient mucosal infection depends on the expres-
sion of gp82, which promotes the adhesion to gastric
mucin, the first step towards the penetration into the
underlying epithelial cells.
GP35/50, THE CA2+ SIGNAL-INDUCING MOLECULE
THAT PROMOTES CELL INVASION OF POORLY
INVASIVE T. cruzi ISOLATES
The involvement of mucin-like gp35/50 molecules
in mammalian cell invasion was determined by
inhibition of MT internalization using MAb 10D8
or the purified native glycoprotein (Yoshida et al.
1989, Ruiz et al. 1993). Like gp82, gp35/50 bind
to target cells in a receptor-mediated manner and
triggers bidirectional Ca2+ response, but to a lower
degree than gp82 (Ruiz et al. 1998).
Gp35/50 mucins are expressed in metacyclic
forms and epimastigotes of all T. cruzi isolates ex-
amined to date. They are encoded by large multi-
gene family (Di Noia et al. 1998) and are detected
in SDS-PAGE gels as two-three bands displaying
isolate-dependent size polymorphism (Mortara et
al. 1992). Gp35/50 molecules are GPI-anchored
glycoproteins rich in threonine. Glycans are O-
linked to threonine residues in the mucin protein
core through N-acetylglucosamine, rather than N-
acetylgalactosamines as usually found in vertebrate
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mucins and, depending on the T. cruzi isolate, may
contain galactofuranose residues in addition to ga-
lactopyranose (Previato et al. 1994, Acosta-Serrano
et al. 1995, Salto et al. 2000). MAb 10D8, that
recognize gp35/50 mucins in MT of poorly invasive
isolates, such as G and Tulahuen, and partially neu-
tralize their infectivity (Yoshida et al. 1989), reacts
with epitopes containing galactofuranose, whereas
MAb 2B10 appears to react with galactopyranose-
containing epitopes present in all isolates.
T. cruzi mucins are the main acceptors of
sialic acid in trans-sialidase (TS)-mediated reaction
(Schenkman and Eichinger 1993). TS is an enzyme
that specifically transfers (α2-3)-linked sialic acid
from extrinsic host-derived macromolecules to O-
linked oligosaccharides of T. cruzi mucin-like gly-
coproteins (Schenkman et al. 1991b, Schenkman
and Eichinger 1993). The enzyme, that is up to
30 times more active in TCT than in MT (Acosta-
Serrano et al. 2001), was first identified in TCT and
bloodstream trypomastigotes as a developmentally
regulated sialidase that releases sialic acid from hu-
man erythrocytes and plasma glycoprotein (Pereira
1983). Using T. cruzi epimastigotes, Previato et al.
(1985) found that sialic acid from exogenous sialy-
lated glycoconjugates is incorporated into parasite
macromolecules. TS preferentially tranfers sialyl
residues to available galactose acceptors and acts as
a sialidase in the absence of appropriate amounts
of suitable acceptors (Schenkman and Eichinger
1993). In MT, sialyl residues are transferred ex-
clusively into gp35/50 mucins (Schenkman et al.
1993a).
Sialyl residues of gp35/50 mucins are not re-
quired for MT invasion, they may rather impair the
interaction with target cells. Treatment of MT of G
isolate with bacterial neuraminidase, for instance,
removes sialic acid from gp35/50 and increases the
parasite infectivity (Yoshida et al. 1997). Resialy-
lation of gp35/50, by incubation of parasites with
T. cruzi TS and sialyl lactose, restores the reactivity
with lectin or monoclonal antibody specific for sialic
acid and, accordingly, reduces the rate of MT entry
into target cells to levels similar to those before de-
sialylation. Compatible with this finding, the capac-
ity to bind to host cells and to trigger Ca2+ response
was found to be higher in desialylated gp35/50 as
compared to its sialylated counterpart (Yoshida
et al. 1997). Infectivity of CL isolate MT is not
affected by neuraminidase treatment because these
parasites rely on gp82, rather than on gp35/50, for
their internalization.
In MT that preferentially engage gp35/50
to invade host cells, as is the case of G isolate, the
signaling cascade triggered in the parasite is distinct
from that induced by gp82 (Fig. 5). PTK and PLC
are not implicated, instead cyclic AMP (cAMP) may
play a role, as deduced from the increased parasite
infectivity upon treatment with adenylyl cyclase ac-
tivator forskolin (Neira et al. 2002). The Ca2+ re-
quired for cell invasion appears to be released from
acidocalcisomes, the vacuoles containing a Ca2+/H+
exchange system (Docampo et al. 1995), provided
that treatment of MT with a combination of iono-
mycin plus NH4Cl or nigericin, that releases Ca2+
from these acidic compartments, significantly di-
minishes target cell entry (Neira et al. 2002). How
gp35/50, an GPI-anchored molecule, relays the ex-
ternal signal to the parasite interior, and what are the
components required for that process are questions
that remain unanswered.
GP90, THE MT-SPECIFIC DOWN REGULATOR OF
HOST CELL INVASION
The property of gp90 as a negative regulator of tar-
get cell invasion was demonstrated by experiments
using antisense oligonucleotides targeted to gp90
gene sequences. Treatment of MT of G isolate with
antisense oligonucleotides reduced the expression
of gp90 and increased the parasite ability to enter
host cells, whereas their sense counterparts or the
mismatched sequences had no effect (Málaga and
Yoshida 2001).
GP90 is a metacyclic stage-specific glycopro-
tein containing N-linked oligosaccharides (Yoshida
et al. 1990). It binds to mammalian cells in a recep-
tor-mediated manner but, unlike gp82 or gp35/50,
does not trigger Ca2+ signal, and intracellular Ca2+
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is not mobilized in the parasite upon binding of anti-
gp90 MAb 1G7, in contrast to what happens upon
interaction with monoclonal antibodies directed to
gp82 or gp35/50 (Ruiz et al. 1998). In MT, the in-
teraction of gp90 with its receptor may trigger an
inhibitory pathway, similarly to cells of the immune
system where, in addition to activation signals, sig-
naling cascades acting as negative regulators can be
induced (Veillette et al. 2002, Vivier et al. 2004).
Like NK cell surface inhibitory receptors that an-
tagonize activation pathways using protein tyrosine
phosphatases (Vivier et al. 2004), gp90 mediates the
activation of MT tyrosine phosphatase that counter-
acts the action of PTK by dephosphorlylating p175
(Manque et al. 2003).
Like gp82 and gp35/50, gp90 is also anchored
to the plasma membrane via GPI (Schenkman et
al. 1988b). The type of association of these GPI-
anchored molecules with other components of the
plasma membrane is unknown. One possibility is
the interaction through their extracellular domains.
Another possibility is the association through GPI
lipid moiety, and in this case the nature of the lipid
may influence which plasma membrane molecule
is recruited. Of note in this regard is that the lipid
portion of gp35/50 GPI from noninfective epimas-
tigotes is composed essentially of 1-O-hexadecyl-
2-O-hexadecanoyl-PI and of 1-O-hexadecyl-2-O-
octadecanoyl-PI, whereas that of metacyclic stage
gp35/50 is mainly ceramide-PI (Acosta-Serrano et
al. 1995).
MECHANISMS OF MT INVASION OF GASTRIC
MUCOSAL EPITHELIUM UPON ORAL INFECTION
MT, but not blood trypomastigotes, have uniquely
specialized functions for mucosal invasion and effi-
ciently enter gastric mucosal epithelium (Hoft 1996,
Hoft et al. 1996). This is in accord with the no-
tion that metacyclic and bloodstream trypomastig-
otes are morphologically similar but are physiologi-
cally distinct (Tyler and Engman 2001). Hoft (1996)
suggested that MT express stage-specific surface
molecules required for adhesion to mucosal epithe-
lial surface receptors and/or for penetration of mucin
coat. This hypothesis has been supported by results
from experiments of oral infection in mice and in
vitro cell invasion assays mimicking the in vivo con-
ditions (Neira et al. 2003, Cortez et al. 2003). Based
on these data, the following sequence of events can
be visualized (Fig. 6). When MT reach the stom-
ach, they resist destruction because they are pro-
tected by protease-resistant gp35/50 mucins, which
are abundant on the parasite surface. Pepsin diges-
tion leaves intact the gp82 domain containing both
the target cell and the gastric mucin-binding sites.
The parasites bind to gastric mucin through gp82
(Fig. 6A) and traverse the mucus to reach the under-
lying epithelial cells. It has as yet to be demon-
strated, but it is possible that T. cruzi has muci-
nase activity, like Entamoeba histolytica, which ex-
presses cyteine proteinases that disrupt the poly-
meric structure of colonic mucin (Moncada et al.
2003), or Trichomonas vaginalis, which invades
vaginal mucous layer by secreting mucinase (Lehker
and Sweeney 1999). Preliminary experiments in-
dicate that T. cruzi secrets an enzyme that acts on
gastric mucin.
Once the mucous barrier is overcome, MT of
T. cruzi isolates such as CL efficiently invade gastric
epithelial cells by engaging gp82 (Fig. 6B) and trig-
gering bidirectional Ca2+ response. MT of G isolate
may reach the epithelial cells as effectively as the
CL isolate MT, but their entry may be impaired by
gp90. Some parasites manage to be internalized by
engaging gp35/50 (Fig. 6B).
On the other hand, MT of T. cruzi isolates
expressing gp30, but deficient in gp82, such as 569
and 588, would have difficulty in penetrating the
thick mucin coat, because gp30 binds poorly to gas-
tric mucin. Binding to mucin may be critical for
the effective action of mucinase inasmuch as, with-
out binding, the enzyme would be secreted into the
medium, not onto the mucin layer. The gp82-defi-
cient parasites that manage to translocate through the
mucin coat, and reach the epithelial cells, are then
internalized in gp30-mediated manner, probably as
efficiently as the gp82-expressing MT.
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Fig. 6 – Model of molecular interaction of T. cruzi metacyclic forms with gastric mucin and gastric
mucosal epithelium upon oral infection of mice. In the stomach, MT of different isolates resist
destruction by pepsin and acidic pH because they are protected by protease-resistant gp35/50 mucins.
A) MT of CL and G isolates bind to gastric mucin via gp82, as the first step to traverse the mucin
layer and reach the underlying epithelial cells. Most parasites of gp82-deficient isolate 569 or 588 do
not interact with the mucin coat, but a small number of parasites do so, in gp30 mediated manner. B)
Once the epithelial cells are reached, MT of CL isolate attach to and efficiently invade them in gp82-
dependent manner, whereas MT of gp82-deficient isolate 569 or 588 rely on gp30 for cell invasion.
MT of G isolate enter epithelial cells poorly, due to the preferential adhesion through gp35/50, which
has lower Ca2+ signal-inducing activity than gp82.
TCT MOLECULES IMPLICATED IN HOST
CELL INVASION
Diverse TCT molecules have been implicated in
host cell invasion. These include surface and/or se-
creted components such as Tc-85 containing bind-
ing sites for laminin and cytokeatin 18 (Giordano
et al. 1994, Magdesian et al. 2001), mucins and
TS (Schenkman et al. 1991b), cystein proteinases
(Meirelles et al. 1992) and members of the prolyl
oligopeptidase family of serine proteases (Burleigh
et al. 1997, Grellier et al. 2001).
TC-85 FAMILY AND OTHER TCT COMPONENTS
WITH AFFINITY FOR EXTRA CELLULAR MATRIX
Tc-85, the surface glycoprotein expressed in TCT
was first implicated in mammalian cell invasion
using MAbs that partially block parasite internal-
ization (Alves et al. 1986). Among the members
of Tc-85 family, the best characterized is the
molecule that contains binding sites for laminin
(Giordano et al. 1994, 1999) and host cell cytok-
eratin 18 (Magdesian et al. 2001). The Tc-85 cell
binding site colocalizes to the most conserved mo-
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tif (VTVXNVFLYNR) of the gp85/TS superfamily,
at the C-terminal domain, and does not contain the
laminin-binding site (Magdesian et al. 2001). In
the sequence deduced from laminin-binding Tc-85
cDNA, there is a stretch of 122 amino acid residues
downstream to this conserved motif (Giordano et
al. 1999), whereas in MT gp82 the same motif
localizes closer to the C- terminus, being followed
by 38 residues, of which 14 correspond to the hy-
drophobic GPI-anchor sequence (Araya et al. 1994).
It is possible that this subterminal localization of
conserved motif in MT gp82 precludes its interac-
tion with cytokeratin C18.
The involvement of fibronectin in target cell
invasion by TCT was deduced from experiments
in which the peptide RGDS, corresponding to fi-
bronectin cell attachment site, was found to bind to
the parasite surface and to inhibit its internalization
(Ouaissi et al. 1986b). By using affinity chromatog-
raphy, the TCT ligand for fibronectin was purified
and identified as an 85 kDa protein that inter-
acts with cells bearing fibronectin molecules, such
as human monocytes and neutrophils as well as 3T3
fibroblasts (Ouaissi et al. 1986a).
Another TCT surface molecule with affinity
for extracellular matrix components is penetrin, a
60 kDa protein that selectively binds to heparin,
heparin sulfate and collagen, and promotes fibrob-
last adhesion and penetration (Ortega-Barria and
Pereira 1991). An intriguing observation is that the
recombinant penetrin, expressed in Escherichia coli
and localized on its surface, induced the bacterial
attachment to and penetration into Vero cells in
a proteoglycan- and collagen-inhibitable manner
(Ortega-Barria and Pereira 1991). Assays to probe
the role of host cell heparin and heparan sulfate
glycosaminoglycans in T. cruzi invasion showed
that proteoglycan-deficient mutants of Chinese
hamster ovary (CHO) cells are poor targets for TCT
penetration (Herrera et al. 1994). Penetrin has not
been further characterized and its structure remains
undefined.
A member of the prolyl oligopeptidase (POP)
family of serine proteases, with specificity for hu-
man collagen types I and IV, has been identified
in cell-free extracts of trypomastigotes, amastigotes
and epimastigotes (Santana et al. 1997, Grellier et
al. 2001). The 80 kDa enzyme, denominated POP
Tc80, also hydrolyses fibronectin and appears to be
implicated in host cell invasion. Selective and ir-
reversible inhibitors of POP Tc80 were found to
block TCT entry into nonphagocytic mammalian
cells (Grellier et al. 2001, Bastos et al. 2005).
In T. cruzi infection in vivo, the ability of
diverse trypomastigote molecules in binding to
laminin, fibronectin, collagen, heparin, heparan sul-
fate, heparin, in addition to the hydrolytic activity of
some of them, may be essential for the parasite tran-
sit through the extracellular matrix towards target
cells.
TS AND SIALIC ACID ACCEPTOR MOLECULES
The role of TS in mammalian cell invasion has as
yet to be fully clarified. On the basis that polyclonal
antibodies that block TS activity enhance invasion
of host cells by TCT in vitro, Cavallesco and Pereira
(1988) proposed that the enzyme negatively modu-
lates T. cruzi infection. They also found that, com-
pared to the minor subset of trypomastigotes rec-
ognized by anti-TS antibodies (TS+), the TS- pop-
ulation showed enhanced ability to enter host cells.
By using anti-TS monoclonal antibodies and various
cell types and parasite isolates, Prioli et al. (1990)
confirmed the previous results, reinforcing the hy-
pothesis that TS down regulates T. cruzi infection.
Subsequently, however, contradictory data were re-
ported by the same group. Pereira et al. (1996)
prepared pure TS+ and TS- populations and tested
them for host cell invasion. They found that TS+
trypomastigotes were highly invasive whereas TS-
parasites were extremely inefficient in invading ep-
ithelial cells and fibroblasts. Furthermore, introduc-
tion of small amounts of TS into suspensions of non-
penetrating TS- trypomastigotes converted them to
a highly invasive phenotype (Pereira et al. 1996).
Immunocytochemical studies localized TS on
the surface of TCT and in association with the flag-
ellar pockets, suggesting that the enzyme is also se-
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creted (Souto-Padrón et al. 1990). The shed acute
phase antigen (SAPA), present in T. cruzi-infected
patients and identified as TS, is the secreted form
of enzyme that generates strong immune response
(Pollevick et al. 1991). Whether the secreted form
of TS and the enzyme expressed on TCT surface act
simultaneously during interaction with target cells,
or the action of one of them predominates depend-
ing on the circumstances, is not clear. According to
Ming et al. (1993), TS may function as a counter-
receptor for parasite binding to α2,3-sialyl receptors
on host cells as a prelude to TCT invasion. Alterna-
tively, after binding of TCT to target cells through
another molecule, secreted TS may transfer sialic
acid from the mammalian cell membrane to
the parasite mucins. These transference reactions
could disrupt the binding of sialoadhesins, allow-
ing the parasites to detach and find a new binding
site in order to proceed towards their internalization
(Schenkman and Eichinger 1993).
In TCT, the sialic acid is incorporated by TS
mainly into mucins migrating in SDS-PAGE as a
broad band of 70-200 kDa (Schenkman et al. 1991a,
b). Mucins and sialyl residues apparently are not pri-
mary requirements for TCT invasion (Schenkman et
al. 1993b), although monoclonal antibodies to sialic
acid-containing epitopes inhibit parasite adhesion
to host cells (Schenkman et al. 1991b). On the
other hand, the involvement of target cell sialic acid
in T. cruzi internalization was reported by different
groups, using sialic acid-deficient CHO (Lec2) cells.
Trypomastigotes entered Lec2 cells to a much lower
extent than parental CHO cells, but sialylation by TS
restored parasite adhesion and invasion (Ciavaglia
et al. 1993, Ming et al. 1993, Schenkman et al.
1993b).
CRUZIPAIN, THE MAJOR T. cruzi CYSTEINE PRO-
TEINASE
Murta et al. (1990) identified T. cruzi antigen gp57/
51 as a cysteine proteinase which is active across
pH range 5-7.5. This enzyme, named cruzipain, is
expressed in all developmental forms of differ-
ent T. cruzi isolates (Murta et al. 1990, Paiva et
al. 1998). By using peptidyl diazomethane deriva-
tives, a class of irreversible inhibitors of cysteine
proteinase, the involvement of cruzipain enzyme in
host cell invasion and intracellular development was
inferred (Meirelles et al. 1992). The role of cruzi-
pain in vivo was also determined. Engel et al. (1998)
cured experimental T. cruzi infection by treating
mice with peptide-fluoromethyl ketones, inhibitors
that inactivate cruzipain and arrest intracellular
replication as well as intercellular transmission in
vitro (Harth et al. 1993).
The participation of cruzipain in host cell inva-
sion by TCT is associated with its ability to generate
bradykinin, according to Scharfstein et al. (2000),
who investigated the involvement of B2 type of
bradykinin receptor (B2R) using human umbilical
vein endothelial cells (HUVECs) or CHO cells over-
expressing B2R (CHO-B2R). They found that cap-
topril, an inhibitor of bradykinin degradation
by kininase II, potentiated TCT entry into HUVECs
and CHO-B2R, but not into mock-transfected CHO
cells, whereas the B2R antagonist HOE 140 or mon-
oclonal antibody to bradykinin blocked these ef-
fects. Purified cruzipain enhanced parasite inva-
sion and triggered Ca2+ mobilization in CHO-B2R
in a manner inhibitable by HOE 140 or cruzipain
inhibitor E-64, indicating that the enzyme plays a
role in generating the kinin agonist from cell-bound
kininogen. This kinin-mediated signal transduction
route is not ubiquitous, its activation depending on
the cell type and the parasite isolate used (Scharf-
stein et al. 2000).
It has also been shown that MGTA, an inhibitor
of kininase I, selectively decreases TCT infectivity
for B1R-expressing cells and that addition of B1R or
B2R antagonists to host cells coexpressing these re-
ceptors inhibit parasite infectivity to a similar extent
(Todorov et al. 2002). Because the combined appli-
cation of both antagonists had no additive effect on
both cardiomyocytes and HUVECs, the authors de-
duced that B1R and B2R operate interdependently to
meet the intracellular Ca2+ concentration threshold
required for efficient TCT internalization.
Processing of kininogens presumably takes
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place within the secluded spaces formed by juxta-
position of parasite and the target cell, inasmuch
as membrane-permeable but not soluble cruzipain
inhibitors block parasite invasion of cells that natu-
rally overexpress kinin receptors (Scharfstein et al.
2000, Todorov et al. 2002). Cruzipain appears to
be modulated by both the host and T. cruzi com-
ponents. On the premise that kininogen molecules
may be displayed on cell surfaces by binding to
glycosaminoglycans, Lima et al. (2002) examined
whether the ability of cruzipain to release kinins
from high molecular weight kininogen is mod-
ulated by heparin sulfate. In the presence of hep-
arin sulfate, they found an enhancement of 6-fold in
cruzipain activity towards synthetic substrates and
of up to 35-fold by direct measurement of
bradykinin. On the other hand, a tight-binding cys-
teine proteinase inhibitor, chagasin, was identified
in T. cruzi (Monteiro et al. 2001). It is localized
in the flagellar pocket and cytoplasmic vesicles of
TCT, and its expression is inversely correlated with
that of cruzipain.
T. cruzi OLIGOPEPTIDASE B
A soluble factor of unknown structure, secreted by
TCT, is so far the sole component of this T. cruzi
developmental form reported to directly trigger
Ca2+ response in host cells. This soluble factor is
generated by the action of a 120 kDa alkaline pep-
tidase on precursors present only in infective try-
pomastigotes (Burleigh and Andrews 1995). The
purified peptidase is devoid of Ca2+ signaling ac-
tivity on its own and is also present in noninfective
epimastigotes (Burleigh and Andrews 1995).
By cloning and sequencing of the correspond-
ing cDNA, the TCT peptidase was found to be a
cytosolic enzyme closely related to members of the
prolyl oligopeptidase family of serine endopepti-
dases, and was denominated T. cruzi oligopeptidase
B (Burleigh et al. 1997). The oligopeptidase B
null mutant trypomastigotes are defective in mo-
bilizing Ca2+ from thapsigargin-sensitive stores in
mammalian cells, and in establishing infection in
vitro and in vivo (Caler et al. 1998). Based on
experimental evidences, it has been proposed that
the Ca2+ agonist generated by oligopeptidase B is
exported from the parasite, binds to a receptor on
the surface of target cells, activating phospholipase
C and generating IP3, which binds to its receptor
on the membrane of the endoplasmic reticulum and
promotes Ca2+ release.
OTHER T. cruzi MOLECULES
Several other T. cruzi molecules have been impli-
cated in host cell invasion. Surface antigens with
metalloprotease activity, which are homologous to
Leishmania gp63, were identified in MT and TCT
and affinity-purified antibodies to these antigens in-
hibited host cell invasion by ∼50% (Cuevas et al.
2003).
Moro et al. (1995) characterized a secreted
T. cruzi protein with peptidyl-prolyl cis-trans iso-
merase activity, susceptible to inhibition by the im-
munosuppressant FK506 and related drugs, and
showed that the addition of the recombinant
protein to simian epithelial or HeLa cells en-
hances parasite invasion. The monomeric protein
has a peptidyl-prolyl cis-trans isomerase core, en-
compassing the characteristic rotamase hydropho-
bic active site, and its mechanism of action may be
the triggering of host cell signal, with or without
the contribution of rotamase activity (Pereira et al.
2002).
A 67 kDa lectin-like glycoprotein, which binds
to desialylated human erythrocyte membranes in a
galactose-dependent way and recognizes receptors
in mouse cardiac tissue and human cardiac aortic
endothelium, has been described and the cell in-
vasion inhibitory effect of anti-gp67 antibodies re-
ported (Silber et al. 2002).
SIGNAL TRANSDUCTION IN HOST CELL DURING
T. cruzi INVASION
CA2+ SIGNALING AND LYSOSOME RECRUITMENT IN
TARGET CELLS
In 1994, Tardieux et al. (1994) reported that TCT,
or their isolated membranes, but not the non-
infective epimastigotes, induce repetitive cytosolic-
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free Ca2+ transients in normal rat kidney (NRK) fi-
broblasts, and that parasite entry is inhibited
by depletion of host cell cytosolic-free Ca2+ or pre-
treatment with Ca2+ channel blockers. In addition
to NRK cells, soluble fraction of TCT induced Ca2+
response in a variety of cell types, such as hamster
CHO and Dede, dog MDCK, monkey CV-1, human
A7 (Burleigh and Andrews 1995), L6E9 myoblasts
(Moreno et al. 1994) and isolated primary canine
cardiac myocytes (Barr et al. 1996). MT were
also found to trigger Ca2+ signaling in diverse cell
types which included human epithelial HeLa cells
and macrophages (Dorta et al. 1995, Wilkowsky
et al. 1996). IP3, generated upon PLC activation,
mediated intracellular Ca2+ mobilization triggered
by TCT soluble factor (Rodriguez et al. 1995).
According to Andrews (1995), host cell Ca2+
response induces the recruitment of lysosomes to
the site of T. cruzi penetration. At that site, lysoso-
mal markers are immediately incorporated into par-
asitophorous vacuole without accumulation of poly-
merized actin around the recently internalized par-
asites, and invasion is facilitated by disruption of
microfilaments (Tardieux et al. 1992). Lysosome
redistribution and TCT invasion of NRK or L6E9
cells is inhibited upon treatment with microtubule-
binding drugs nocodazole, colchicine, vinblastine
and taxol, or after microinjection with antibodies to
kinesin, indicating that lysosome transport is me-
diated by microtubule/kinesin (Rodriguez et al.
1996). Recently, Jaiswal et al. (2002) reported that
lysosomes that fused were predominantly pre-
docked at the plasma membrane, Ca2+ being
primarily responsible for fusion and not recruit-
ment of lysosomes to the cell surface. By fusing
with the plasma membrane, lysosomes would con-
tribute to formation of the parasitophorous vacuole
(Andrews 1995).
Elevation in intracellular free Ca2+ concentra-
tion triggered lysosome fusion and exocyto-
sis, as deduced from the appearance on the plasma
membrane of the lysosomal glycoprotein lgp120,
and the release of the lysosomal enzyme beta-
hexosaminidase or the lysosomally processed form
of cathepsin D (Rodriguez et al. 1997). Ca2+-
dependent exocytosis of lysosomes is cAMP-
regulated and is enhanced by isopreternol, a
β-adrenergic agonist that activates adenylyl cyclase
through heterotrimeric G protein Gs (Rodriguez et
al. 1999). Sinaptotagmin VII, a ubiquitously ex-
pressed sinaptotagmin isoform that is localized on
the membrane of lysosomes in different cell types
and regulates exocytosis of these organelles, ap-
pears to mediate T. cruzi invasion. TCT entry was
impaired in CHO cells loaded with antibodies that
recognize the Ca2+-binding domain of sinaptotag-
min VII and inhibit the Ca2+-triggered exocytosis of
lysosomes (Caler et al. 2001).
Targeted lysosome exocytosis may not be the
predominant mechanism by which TCT gain access
to non-professional phagocytic cells. It has been
found that only a minimal fraction of invading TCT
associate with host cell lysosomes whereas the ma-
jority of parasites induce plasma membrane invagi-
nation and the TCT-containing vacuoles gradually
acquire lysosomal markers (Woolsey et al. 2003).
The newly forming T. cruzi compartments first inter-
act with an early endosome compartment and sub-
sequently with other late endosomes, before inter-
action with lysosomes (Wilkowsky et al. 2002).
HOST CELL ACTIN CYTOSKELETON
As a rapid and transient reorganization of host cell
microfilaments is induced by TCT soluble factor
and live trypomastigotes, probably as a direct con-
sequence of increased intracellular Ca2+ concentra-
tion, it has been proposed that this disassembly of
the cortical actin cytoskeleton plays a role in T. cruzi
invasion (Rodriguez et al. 1995). In accord with this
hypothesis is the observation that treatment of NRK
cells with cytochalasin D, a drug that disrupts micro-
filaments, enhances TCT internalization (Tardieux
et al. 1992, Caler et al. 2000). However, such an
effect has not been detected by other groups. Cy-
tochalasin D had little or no effect on TCT entry into
MDCK or HeLa cells (Schenkman et al. 1991c)
whereas marked inhibiton was detected in diverse
cell types, including Vero, LLCMK 2, HFSF fibrob-
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last, L-6 skeletal muscle myoblast and resident peri-
toneal macrophages (Rosestolato et al. 2002), in ad-
dition to heart muscle cells (Barbosa and Meirelles
1995). As regards MT invasion, it was significantly
inhibited by treatment of HeLa cells with cytocha-
lasin B or latrunculin B (Osuna et al. 1993), but
unaffected by cytochalasin D (Schenkman and
Mortara 1992). It is not clear why the results from
different groups differ so widely, provided that ap-
parently the experimental conditions and the drug
concentration used are similar.
Recent data implicate the actin cytoskeleton in
the intracellular retention of parasites. Woolsey and
Burleigh (2004) demonstrated that cytochalasin D
treatment of host cells inhibits early lysosome as-
sociation with invading TCT by uncoupling the cell
penetration step from lysosome recruitment and/or
fusion, and prolonged disruption of actin microfila-
ments results in significant loss of internalized par-
asites from infected cells. That a significant frac-
tion of the internalized parasite is not retained in-
side host cells for a productive infection was con-
firmed by Andrade and Andrews (2004), by block-
ing lysosome-mediated TCT invasion through phos-
phoinositide 3-kinase inhibition.
An interesting observation, that reinforces the
role of the cortical actin cytoskeleton disassembly
in T. cruzi invasion, has been made in human pla-
centa syncytiotrophoblasts. Using immunohisto-
chemical techniques, Sartori et al. (2003a) ob-
served the presence of actin in the syncytiotro-
phoblasts throughout the brush border in placentae
from non-chagasic women but, after culture with
trypomastigotes, this labeling disappeared, indicat-
ing that the parasite induced disassembly of the
cortical actin cytoskeleton.
PHOSPHOINOSITIDE (PI)-3 KINASES,
PROTEIN KINASES AND PHOSPHATASES
Among the mechanisms of T. cruzi invasion
are those dependent on lipid as well as protein ki-
nases. Infection of macrophages with trypomastig-
otes stimulates the formation of the lipid products
of PI 3-kinases and treatment with wortmannin, an
inhibitor of PI 3-kinases, impaires parasite internal-
ization (Todorov et al. 2000). Immunofluorescence
microscopy, using antibodies against p85, the regu-
latory subunit of PI 3-kinase, localized the enzyme
at the site of parasite interaction with macrophages,
which was rich in F-actin (Vieira et al. 2002). In ad-
dition to phagocytic human macrophages and J774
murine cells, nonphagocytic Vero, L6E9 and 3T3
cells become less susceptible to T. cruzi infection
upon treatment with wortmannin (Wilkowsky et al.
2001). According to Woolsey et al. (2003), host cell
PI 3-kinases activated by TCT early in the cell inva-
sion process regulate lysosome-dependent parasite
entry. Treatment of T. cruzi with wortmannin also
inhibited parasite internalization (Wilkowsky et al.
2001), indicating that both parasite and target cell
PI 3-kinase activities are implicated in cell invasion.
The involvement of protein tyrosine kinase
(PTK) in T. cruzi invasion of macrophages has been
reported by Vieira et al. (1994). By treating ei-
ther TCT or macrophages with genistein, a spe-
cific PTK inhibitor, these authors found a signifi-
cant decrease in parasite endocytosis. Monoclonal
anti-phosphotyrosine antibodies revealed an accu-
mulation of tyrosine-phosphorylated residues at the
site of parasite association with the macrophage sur-
face, colocalizing with host cell F-actin-rich do-
mains (Vieira et al. 2002). Activation of parasite
PTK is required for MT and TCT entry into non-
phagocytic cells (Favoreto et al. 1998) but, in con-
trast to what is seen in macrophages, host cell PTK
activity is not involved, as inferred from the lack of
inhibition of TCT or MT internalization upon
treatment of RNK or HeLa cells with genistein
(Rodriguez et al. 1995, Favoreto et al. 1998).
Other protein kinases also participate in T.
cruzi entry into host cells. Wilkowsky et al. (2001)
found that infection of transiently transfected 3T3
cells containing an inactive mutant protein kinase B
are less susceptible to invasion, as compared to the
active mutant-transfected cells. Activation of pro-
tein kinase C and enhancement of parasite uptake
by macrophages have been detected upon incuba-
tion with recombinant gp83, a TCT surface ligand
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(Villalta et al. 1999).
Activation of the host cell PTK is not required
for T. cruzi invasion of nonphagocytic cells. On
the other hand, protein tyrosine phosphatases appear
to be involved. Invasion of TCT induced tyrosine
dephosphorylation of several proteins in L6E9 my-
oblasts, and the parasite internalization was greatly
reduced in the presence of protein tyrosine phos-
phatase inhibitors and in the presence of excess
phosphotyrosine, but not of phosphoserine or phos-
phothreonine (Zhong et al. 1998). In human HEp2
tumor cells, infection with T. cruzi resulted in the
alterations of their placental alkaline phosphatase
activity as well as in a different pattern of actin or-
ganization, compared to control cells, and the in-
terference in the enzyme activity before infection
decreased the invasion rate (Sartori et al. 2003b).
TARGET CELL SURFACE MOLECULES IMPLICATED
IN SIGNAL TRANSDUCTION AND TCT INVASION
In addition to Ca2+ signaling through bradykinin re-
ceptor, the signaling route mediated by transform-
ing growth factor-β (TGFβ) receptor may be acti-
vated during TCT invasion of target cells. In a series
of experiments, Ming et al. (1995) showed the re-
quirement of TGFβ pathway for T. cruzi invasion
of epithelial cells. They found that TCT attached
to TGFβ receptor-deficient epithelial cell lines, but
were unable to penetrate. Susceptibility to T. cruzi
infection was restored by transfection with TGFβ
receptor genes, and treatment with TGFβ greatly
enhanced parasite internalization. As a TGFβ-
responsive reporter gene is induced in TGFβ-
sensitive cell lines by TCT, but not by noninvasive
epimastigotes, Ming et al. (1995) postulated that T.
cruzi may directly trigger activation of the TGFβ-
signaling pathway required for invasion. The pu-
tative TGFβ-like factor from TCT has never been
characterized.
In macrophages, the heterodimeric β1 inte-
grins, which belong to a ubiquitous family of in-
tegral membrane proteins that link the extracellular
matrix to the cortical cytoskeleton, may be involved
in signal transduction and T. cruzi internaliza-
tion. Fernandez et al. (1993) observed that, when
added to human macrophages, monoclonal antibod-
ies to β1 subunit of VLA integrin family specifically
blocked T. cruzi uptake, without interfering with
the uptake of Leishmania pinfanoi or Escherichia
coli. As that inhibition correlated with the ability
to block fibronectin binding to macrophages, it is
uncertain whether the parasite interacts with VLA
directly or through the binding to fibronectin.
Galectin 3, which increases K-Ras activation
and triggers a Ras signal (Elad-Sfadia et al. 2004),
is another host cell component that may partici-
pate in T. cruzi invasion. In experiments with hu-
man coronary artery smooth muscle cells, that ex-
press galectin-3 on the surface and also secret it,
Kleshchenko et al. (2004) found that exogenously
added galectin-3 increases trypomastigote binding.
T. cruzi adhered poorly to cells with reduced expres-
sion of galectin-3, but the adhesion property was
restored by exogenous galectin-3.
MECHANISMS OF TARGET CELL INVASION BY
BLOOD TRYPOMASTIGOTES
From the data of in vitro studies with TCT,
the possible mechanisms that the bloodstream
trypomastigotes may use to invade host cells can
be envisaged (Fig. 7). Before reaching the target
cells, in many instances the parasites have to over-
come the barrier of extracellular matrix, in the same
manner as MT encounter the mucin coat in the stom-
ach. Through the surface molecules of gp85/TS su-
perfamily, the parasites bind to fibronectin/laminin
(Fig. 7A) and pave the way for the action of en-
zymes, such as the serine protease POP Tc80 that
hydrolyses collagen/fibronectin (Fig. 7B).
Upon encountering the target cells, trypomas-
tigotes attach to them in a manner mediated by Tc-
85, TS or mucin (Fig. 7C). This interaction induces
the activation of T. cruzi oligopeptidase B that gen-
erates a Ca2+ signaling factor from a precursor
molecule. Triggering of host cell Ca2+ mobiliza-
tion by this secreted parasite factor promotes inva-
sion. Alternatively, or simultaneously, cruzipain is
secreted by attached trypomastigotes within the con-
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Fig. 7 – Model of molecular interaction of T. cruzi bloodstream trypomastigotes with target cells.
The extracellular matrix may constitute in many instances a barrier trypomastigotes have to over-
come to reach the host cells. A) TCT attach to the extracellular matrix using molecules such as
gp85 and penetrin, which have affinity for laminin, fibronectin, collagen, heparin. B) To translocate
through the matrix, the parasite may use POP Tc80, which has collagen/fibronectin hydrolyzing
activity. C) Adhesion to and invasion of target cells can be mediated by gp85, TS and/or mucins.
D) Binding of TCT to target cells induce the activation of oligopeptidase B that generates a Ca2+
agonist, as well as the secretion of cruzipain that indirectly triggers Ca2+ response in host cells.
fines of parasite-target cell juxtaposition, and its ac-
tion on the kininogen generates bradykinin, which
also induces Ca2+ response by interacting with its
receptor (Fig. 7D). Trypomastigotes of T. cruzi iso-
lates that trigger both signaling pathways may be
more invasive. By testing different T. cruzi isolates,
Aparicio et al. (2004) have found a correlation be-
tween the level of secreted cruzipain and the capac-
ity of trypomastigotes to invade host cells. The low
invasive capacity of G isolate, with low levels of
cruzipain, may result from the lack of activation of
cruzipain-mediated signaling pathway. In addition
to the referred signaling routes, parasite-target cell
interactions mediated by TGFβ receptors and β1
integrins may take place, further contributing to the
process of parasite internalization.
CONCLUDING REMARKS
Activation of signal transduction pathways trig-
gered in the parasite and the host cell, leading to
intracellular Ca2+ mobilization, Ca2+-induced reor-
ganization of the host cell actin cytoskeleton and
lysosome recruitment, constitutes the general
mechanism by which T. cruzi trypomastigotes
invade mammalian cells. With a plethora of T. cruzi
molecules that have been identified and character-
ized structural and functionally, plus the identifica-
tion of target cell components involved, the whole
process is beginning to be understood at the
molecular level. The picture is complex. Not only
MT and TCT engage different molecules to interact
with host cells, but different T. cruzi isolates may
use distinct sets of molecules, activating distinct sig-
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naling pathways. In addition, some molecular in-
teractions may trigger inhibitory signals that down
regulate trypomastigote invasion. Furthermore, as
the in vivo infection is concerned, the interaction
of parasites with host components before reaching
the target cells has also to be considered. Great
progress has been made towards understanding the
mammalian cell invasion by T. cruzi, but a lot more
work has to be done before we can draw a more
complete and detailed picture of that process.
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RESUMO
O estabelecimento da infecção por Trypanosoma cruzi,
o agente da doença de Chagas, depende de uma série de
eventos envolvendo interações de diversas moléculas do
parasita com componentes do hospedeiro. Focalizamos
aqui os mecanismos de invasão celular por tripomastigo-
tas metacíclicos (TM) e por tripomastigotas de cultura de
tecido (TCT). Durante a internalização de TM ou TCT,
vias de transdução de sinal são ativadas tanto no para-
sita como na célula alvo, acarretando a mobilização de
Ca2+. Para adesão, TM utiliza as glicoproteínas de super-
fície como a gp82 e gp35/50, que são moléculas indutoras
de sinal de Ca2+. Em isolados de T. cruzi que entram
na célula hospedeira de maneira dependente de gp82, a
proteína tirosina quinase assim como a fosfolipase C do
parasita são ativadas, e Ca2+ é liberado de reservatórios
sensíveis a IP3, enquanto em isolados de T. cruzi que se
ligam às células alvo através de gp35/50, a via de sinali-
zação envolvendo adenilil ciclase parece ser estimulada,
com liberação de Ca2+ de acidocalciossomos. Além disso,
dependendo do isolado de T. cruzi, sinais inibitórios medi-
ados por gp90 específica de TM podem ser desencadeados
tanto na célula hospedeira como no parasita. O repertório
de moléculas de TCT implicadas na invasão celular inclui
glicoproteínas de superfície da família gp85, com mem-
bros contendo sitos de ligação à laminina e citoqueratina
18, enzimas como a cruzipaína, trans-sialidase, e uma
oligopeptidase B que gera um agonista de Ca2+ a par-
tir de uma molécula precursora.
Palavras-chave: Trypanosoma cruzi, tripomastigotas, in-
vasão celular, transdução de sinal, mobilização de Ca2+.
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